Trade Lead Description:
Keyword:
CAS Registry Number: 21187-98-4
Standard: EP6
Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. It is marketed as Glyloc and Reclide in India and Diamicron in Canada. In the Philippines, it is marketed as Glubitor-OD. It is not marketed in the United States. A modified-release formulation is also marketed. Its classification has been ambiguous, as literature uses it as both a first-generation and second-generation sulfonylurea.
Each tablet contains 80, 60, or 30 mg of gliclazide. In the Philippines, it is only available in 30 mg or 80 mg doses。
SPECIFICATION:
Properties
Hypoglycemic sulfonylurea, restoring first peak of insulin secretion, increasing insulin sensitivity.
Glycemia-independent hemovascular effects, antioxidant effect.
No active circulating metabolites.
Gliclazide is used for control of hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, maturity-onset or adult type.
| Type of Offer: |
Offer to Sell |
| Quantity: |
Not Specified |
| Packaging: |
25kg/bag |
| Price / Incoterms Conditions: |
Not Specified |
Posted from China - Henan on 19 March, 2012
Last Modified on 16 April, 2012
|
|
Trade Leads Directory -> All Trade Leads -> Health & Beauty -> Drugs & Medications -> Gliclazide
US, Canada, UK, China, India, Malaysia, United Arab Emirates, Australia and New Zealand Companies
